The sEV PD-L1 level in CD3+ sEVs, but not CD3− sEVs, from patients with stage III-IV NSCLC was significantly higher than that of patients with stage I-II NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.